Related references
Note: Only part of the references are listed.Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment
Jose Perez de los Cobos et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar
Ignacio Ortega et al.
PHARMACEUTICAL RESEARCH (2007)
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers
C. B. Eap et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Enantiomeric metabolic interactions and stereoselective human methadone metabolism
Rheem A. Totah et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Pharmacogenetics of opioids
Andrew A. Somogyi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
ABCB1 and cytochrome P450 genotypes and phenotypes:: Influence on methadone plasma levels and response to treatment
Severine Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
Janet K. Coller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
The μ-opioid receptor gene polymorphism 118A > G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carries
Bruno G. Oertel et al.
PHARMACOGENETICS AND GENOMICS (2006)
Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver
Yvonne Meier et al.
HEPATOLOGY (2006)
Drug-induced long QT syndrome in injection drug users receiving methadone - High frequency in hospitalized patients and risk factors
Georg B. Ehret et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Transporters as a determinant of drug clearance and tissue distribution
Y Shitara et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb
CANCER LETTERS (2006)
G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression
PF Song et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1)
Danxin Wang et al.
AAPS JOURNAL (2006)
Expression and function of efflux drug transporters in the intestine
M Takano et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes
RHN van Schaik
INVESTIGATIONAL NEW DRUGS (2005)
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
S Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract
M Thörn et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Role of P-glycoprotein in transplacental transfer of methadone
T Nanovskaya et al.
BIOCHEMICAL PHARMACOLOGY (2005)
How individual sensitivity to opiates can be predicted by gene analyses
K Ikeda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Polymorphism of μ-opioid receptor gene (OPRM1:c.118A >G) does not protect against opioid-induced respiratory depression despite reduced analgesic response
RR Romberg et al.
ANESTHESIOLOGY (2005)
Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver
A Owen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Are μ-opioid receptor polymorphisms important for clinical opioid therapy?
J Lötsch et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Effect of genetic polymorphisms in cytochrome P450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs - Clinical relevance
J Kirchheiner et al.
CLINICAL PHARMACOKINETICS (2005)
The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone
ED Kharasch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Genetics of the variable expression of CYP3A in humans
L Wojnowski
THERAPEUTIC DRUG MONITORING (2004)
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice
JS Wang et al.
PSYCHOPHARMACOLOGY (2004)
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-α-methadol in opioid-naive individuals
DE Moody et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens
K Tsuchiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Subjective and physiological responses among racemicmethadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure
TB Mitchell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
LMS Chan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance
C Marzolini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The 118 A > G polymorphism in the human μ-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2004)
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
JG Gerber et al.
CHIRALITY (2004)
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor
A Beyer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
ABC of oral bioavailability: transporters as gatekeepers in the gut
CG Dietrich et al.
GUT (2003)
QTc interval prolongation associated with intravenous methadone
CA Kornick et al.
PAIN (2003)
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6
J Kirchheiner et al.
PHARMACOGENETICS (2003)
A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment
MR Shiran et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro
JS Wang et al.
DRUG METABOLISM AND DISPOSITION (2003)
Functional characterization of cytochrome P4502B6 allelic variants
H Jinno et al.
DRUG METABOLISM AND DISPOSITION (2003)
Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses
M Shinderman et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Methadone maintenance treatment and St. John's Wort - A case report
D Eich-Hochli et al.
PHARMACOPSYCHIATRY (2003)
Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers
C Skarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Hepatic CYP2B6 expression: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (Constitutive Androstane Receptor) expression
V Lamba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
HJ Xie et al.
PHARMACOGENOMICS JOURNAL (2003)
Pharmacokinetic interactions with rifampicin - Clinical relevance
M Niemi et al.
CLINICAL PHARMACOKINETICS (2003)
Torsade de Pointes associated with very-high-dose methadone
MJ Krantz et al.
ANNALS OF INTERNAL MEDICINE (2002)
Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population
M Hiratsuka et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer
AB Spurdle et al.
PHARMACOGENETICS (2002)
Clinical pharmacology of opioids for pain
CE Inturrisi
CLINICAL JOURNAL OF PAIN (2002)
Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan
A Bulka et al.
BRAIN RESEARCH (2002)
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers
S Begré et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Methadone and fluconazole: Respiratory depression by drug interaction
Y Tarumi et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor
NM Williams et al.
MOLECULAR PSYCHIATRY (2002)
Interindividual variability of the clinical pharmacokinetics of methadone - Implications for the treatment of opioid dependence
CB Eap et al.
CLINICAL PHARMACOKINETICS (2002)
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
LD Bradford
PHARMACOGENOMICS (2002)
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
J Lotsch et al.
PHARMACOGENETICS (2002)
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba et al.
PHARMACOGENETICS (2002)
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz
SM Clarke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir
PA Bart et al.
THERAPEUTIC DRUG MONITORING (2001)
Frequency of C3435T polymorphism of MDR1 gene in African people
E Schaeffeler et al.
LANCET (2001)
Identification of functionally variant MDR1 alleles among European Americans and African Americans
RB Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate
DW Boulton et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
T Lang et al.
PHARMACOGENETICS (2001)
Identification and functional characterization of eight CYP3A4 protein variants
R Eiselt et al.
PHARMACOGENETICS (2001)
Inverse agonists and neutral antagonists at μ opioid receptor (MOR):: possible role of basal receptor signaling in narcotic dependence
DX Wang et al.
JOURNAL OF NEUROCHEMISTRY (2001)
MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
MM Ameyaw et al.
PHARMACOGENETICS (2001)
Cytochrome P450 2D6 genotype and methadone steady-state concentrations
CB Eap et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
A novel single nucleotide polymorphism altering stability and activity of CYP2A6
N Ariyoshi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia
T Ohtsuki et al.
MOLECULAR PSYCHIATRY (2001)
A single nucleotide polymorphic mutation in the human μ-opioid receptor severely impairs receptor signaling
K Befort et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The relationship between mood state and plasma methadone concentration in maintenance patients
KR Dyer et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment
CB Eap et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis
I Ieiri et al.
THERAPEUTIC DRUG MONITORING (2000)
Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein
SJ Thompson et al.
ANESTHESIOLOGY (2000)
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
F Sata et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Direct and indirect effects of prenatal alcohol damage on executive function
PD Connor et al.
DEVELOPMENTAL NEUROPSYCHOLOGY (2000)
Decreased methadone effect after ritonavir initiation
SM Geletko et al.
PHARMACOTHERAPY (2000)
Share Paper
